Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
针对 BRAF V600E 突变转移性结直肠癌患者的 Binimetinib、Encorafenib 和 Cetuximab 三联疗法:来自 III 期 BEACON 结直肠癌研究的安全性导入结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.18.02459
Van Cutsem, Eric; Huijberts, Sanne; Grothey, Axel; Yaeger, Rona; Cuyle, Pieter-Jan; Elez, Elena; Fakih, Marwan; Montagut, Clara; Peeters, Marc; Yoshino, Takayuki; Wasan, Harpreet; Desai, Jayesh; Ciardiello, Fortunato; Gollerkeri, Ashwin; Christy-Bittel, Janna; Maharry, Kati; Sandor, Victor; Schellens, Jan H M; Kopetz, Scott; Tabernero, Josep